Patents by Inventor Hiroaki Susumu

Hiroaki Susumu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CTLA-4 ANTIBODY AND USE THEREOF
    Publication number: 20240059774
    Abstract: The present disclosure provides anti-CTLA-4 antibodies and methods of producing and using the antibodies. The present disclosure also provides nucleic acids encoding the anti-CTLA-4 antibodies and host cells containing the nucleic acids. Furthermore, the present disclosure provides polypeptides containing a variant Fc region containing amino acid alterations in a parent Fc region and methods of producing and using the polypeptides.
    Type: Application
    Filed: September 19, 2023
    Publication date: February 22, 2024
    Inventors: Hitoshi KATADA, Kanako TATSUMI, Yutaka MATSUDA, Shun SHIMIZU, Masaki KAMIMURA, Yasunori KOMORI, Yuji HORI, Tomoyuki IGAWA, Hiroki KAWAUCHI, Hiroki HAYASHI, Hiroaki SUSUMU
  • ANTI-CTLA-4 ANTIBODY AND USE THEREOF
    Publication number: 20240002510
    Abstract: The present disclosure provides anti-CTLA-4 antibodies and methods of producing and using the antibodies. The present disclosure also provides nucleic acids encoding the anti-CTLA-4 antibodies and host cells containing the nucleic acids. Furthermore, the present disclosure provides polypeptides containing a variant Fc region containing amino acid alterations in a parent Fc region and methods of producing and using the polypeptides.
    Type: Application
    Filed: June 24, 2022
    Publication date: January 4, 2024
    Inventors: Hitoshi KATADA, Kanako TATSUMI, Yutaka MATSUDA, Shun SHIMIZU, Masaki KAMIMURA, Yasunori KOMORI, Yuji HORI, Tomoyuki IGAWA, Hiroki KAWAUCHI, Hiroki HAYASHI, Hiroaki SUSUMU, Shimon SAKAGUCHI
  • ANTI-CTLA-4 ANTIBODY AND USE THEREOF
    Publication number: 20230058982
    Abstract: The present disclosure provides anti-CTLA-4 antibodies and methods of producing and using the antibodies. The present disclosure also provides nucleic acids encoding the anti-CTLA-4 antibodies and host cells containing the nucleic acids. Furthermore, the present disclosure provides polypeptides containing a variant Fc region and methods of producing and using the polypeptides.
    Type: Application
    Filed: December 27, 2019
    Publication date: February 23, 2023
    Inventors: Hitoshi KATADA, Kanako TATSUMI, Kanako ATSUMI, Shun SHIMIZU, Masaki KAMIMURA, Yasunori KOMORII, Yuji HORI, Tomoyuki IGAWA, Hiroki KAWAUCHI, Hiroaki SUSUMU
  • ANTI-CTLA-4 ANTIBODY AND USE THEREOF
    Publication number: 20230020377
    Abstract: The present disclosure provides anti-CTLA-4 antibodies and methods of producing and using the antibodies. The present disclosure also provides nucleic acids encoding the anti-CTLA-4 antibodies and host cells containing the nucleic acids. Furthermore, the present disclosure provides polypeptides containing a variant Fc region containing amino acid alterations in a parent Fc region and methods of producing and using the polypeptides.
    Type: Application
    Filed: June 24, 2022
    Publication date: January 19, 2023
    Inventors: Hitoshi KATADA, Kanako Tatsumi, Yutaka Matsuda, Shun Shimizu, Masaki Kamimura, Yasunori Komori, Yuji Hori, Tomoyuki Igawa, Hiroki Kawauchi, Hiroki Hayashi, Hiroaki Susumu, Shimon Sakaguchi